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abstract
Background: Osteoporosis is a systemic disease that can decrease bone density as a result of imbalance bone remodeling and bone 
resorption. Estrogen reduction due to menopause can increase osteoclast activity and furthermore decrease bone density. Estrogen can 
stimulate alkaline phosphatase (ALP) expression, collagen type I and osteocalcin in bone remodelling process. Ovariectomized rat is 
a common animal for studying patofisiology, diagnosis and treatment osteoporosis patient. Purpose: To evaluate correlation between 
estrogen and ALP expression in osteoporotic rat model mandible. Methode: 18 female wistar rats, 2 months old, 200 grams were 
divided into 2 groups, ovariectomized group and sham surgery as control group. Surgery was done under intra muskular anesthesia 
using combination 2% xylazine 1cc and 10% ketamine 1cc. After 12 weeks, mandible was taken for ALP examination and blood from 
heart was taken to evaluate the amount of estrogen. Result: There was significant correlation between estrogen and ALP expression 
in osteoporotic rat model mandible. Conclusion: The amount of estrogen can influence ALP expression activity. 
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introduction
Oral health condition of elderly patients has an 
important role equal to quality of life, in addition to several 
other life factors, such as socio-economical, physical, and 
psychosocial reasons. Consequently, demand to get better 
dental and oral cavity treatment increases. Based on global 
epidemiological data report, 1 out of 3 women and 1 out 
of every 50 men over the age of 50 years suffered from 
osteoporosis. Several researches even have reported that 
there is a correlation between systemic osteoporosis and 
bone resorption in oral cavity.1
Osteoporosis is a systemic disease that can decrease bone 
density as a result of imbalance between bone formation 
with bone resorption. Postmenopausal osteoporosis is the 
most common form of osteoporosis, leading to increased 
risk of fractures after menopause manifestations such as 
wrist fractures, spine fractures, and hip fractures with a 
mean age over 60 years.2 Bone density is a specific factor 
influencing the risk of bone fractures. According to WHO, a 
state of osteoporosis if bone density more than 2.5 standard 
deviation, below the average for normal young people 
(T<-2.5) in dual energy x-ray absorptiometry (DEXA) 
measurement.3 Moreover, an estimated 40% of women and 
13% of men over at the age of 50 will experience a fracture 
due to osteoporosis.4
Osteoporosis is classified into two categories, namely 
primary osteoporosis and secondary osteoporosis. Primary 
osteoporosis is associated with menopause and aging 
conditions. Meanwhile, secondary osteoporosis is due 
to certain health conditions, along with drug therapies 
that influence bone density or increasing of bone density 
loss. The condition is generally associated with endocrine 
disorders (Cushing syndrome, hyperparathyroidism, 
insulin-dependent diabetes mellitus (IDDM), adrenal 
insufficiency), rheumatoid arthritis, hematological 
disorders, and malignancies (leukemia, lymphoma).5 
Hormonal changes that occur as the condition of 
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menopause are important factors cause decrease women 
bone density.6 The decline in estrogen levels associated 
with post-menopausal osteoporosis condition then can 
increase osteoclasts activity, and subsequently can lead to 
osteoporosis decreasing the attachment of the bone into the 
teeth in the oral cavity.7
There are several methods to measure bone density, such 
as inspection DEXA, which has good accuracy in diagnosis. 
This examination is very important to improve successful 
rate of dental treatment, expecially prosthodontics such 
as complete dentures, partial dentures, as well as dental 
implants. However, the use of this measuring tool has 
limitations in its implementation because it is conducted 
on a particular health facility and the cost is relative 
high. Therefore, simple examination is needed for early 
identification of osteoporosis during dental care, such as a 
examination of estrogen levels and ALP expression. The 
examination may be an option for an early indicator of 
osteoporosis sufferers, which is more efficient with a good 
degree of diagnostic accuracy.
OVX model rats are animals mostly used in a study 
of osteoporosis pathophysiology, focused on its diagnosis 
and treatment. These animals have also been validated 
as a clinically relevant model of post-menopausal bone 
density loss.4 In this research, immunohistochemical 
examination (IHC) was conducted in the osteoporotic rats 
model mandible.
This research was conducted to evaluate estrogen 
levels on mandibular bone ALP expressions in both 
model rats suffering from osteoporosis and normal rats. 
Thus, the results of this research are expected to provide 
information about evaluation of estrogen levels and 
immunohistochemical examination of ALP in both normal 
rats and model rats suffering from osteoporosis. 
materials and method
This research was a laboratory experimental research 
using 18 female Wistar rats, 3 months old. Those animals 
were not in a state of pregnancy, did not suffer from any 
disease, as well as did not undergo hormone therapy. 
This research was approved by Health Research Ethics 
Committee (KKEPK) from Faculty of Dental Medicine, 
Universitas Airlangga No. 15/ KKEPK.FKG/ I/2016.
Wistar rats then were divided into two groups, group of 
SHS (Sham surgery) rats as the control group and the group 
of OVX rats. Model rats suffering from osteoporosis were 
classified into the treatment group. They were weighed 
and had intramuscular anesthesia with a combination of 
2% xylazine (1 cc) and 10% ketamine (1 cc). Ovariectomy 
was performed by making a ventral incision from the 
umbilicus to the pubis. The blood vessels of the ovary and 
the fallopian tubes were ligated separately. The ovarium 
was taken bilaterally, and then the peritoneum incision was 
closed using a simple interrupted suture technique. SHS 
was performed in the control group by making a ventral 
incision from the umbilicus to the pubis, and then returned 
to its previous position and closed the peritoneum incision 
by using a simple interrupted suture technique.9 Those OVX 
female Wistar rats were maintained for 12 weeks in a cage 
with simultaneous treatment, in which they got 12 hours of 
light and 12 hours without light. They were also fed with 
Comfeed concentrate starter (calf starter) containing yellow 
corn, wheat bran, SBM, drops, Palm Olien essential amino 
acids, essential minerals, premix, and vitamin. They also 
got drink at the same time.
Blood samples were obtained after those rats were 
anaesthetized using ketamine before termination. Blood 
samples were taken directly from the heart through the apex 
as much as 3 ml using 5 ml of disposable syringe. Blood 
samples taken from the rat heart were then inserted into 
a test tube and waited for 3 hours to generate serum. The 
serum was centrifuged at 3000 rpm at room temperature 
for thirty minutes with microliter centrifuge (Micro 200, 
Hettich GmbH & Co.KG). Centrifugation process was 
performed to obtain pure serum. The serum then was 
added into eppendrof tubes, and stored in a refrigerator at 
a temperature of 40 C.
To determine estrogen levels in those rats, an 
examination with indirect ELISA method was performed. 
Antigens were derived from the serum of blood samples 
taken from the heart. The blood samples were taken from 
all the experimental animals treated. Indirect ELISA testing 
was performed using 100μL of antigens in coating buffer 
with a ratio of 1: 9, and then put in wells of ELISA plates 
and incubated overnight at a temperature of 40ºC. They 
were washed with PBS-Tween 3 times. They were added 
with 50 mL of blocking buffer (1% BSA in PBS). They 
were washed with PBS-Tween 3 times. They were added 
with 100 mL of primary antibody in 1% PBS-BSA solution 
with a ratio of 1: 500, and then incubated for 2 hours. They 
were washed with PBS-Tween 3 times, added with 100 mL 
of the secondary antibody in Tris buffer saline at a ratio of 
1: 2500, and then incubated for 1.5 hours. They then were 
washed with PBS-Tween 2 times. They were added with 
50 mL of pnpp substrate, incubated for 30 minutes, and 
added with 50 mL of 1N NaOH as the reaction stopper. The 
absorbance was read using ELISA reader at a wavelength 
of 405 nm.10
After blood sample was taken, rats were terminated 
and mandible was taken for immunohistochemistry 
examination. Direct method with a monoclonal antibody 
was used to detect a marker of cells, directly labeled with 
ALP enzyme. To eliminate the activity of endogenous 
Peroxidase, 3% H2O2 was used. To clean protein debris that 
might cover epitope with materials that would be used to 
detect, 0.025% trypsin in PBS was used. IHC examination 
then was conducted by deparaffinization, integrating 
successive tissue incision into xylitol, absolute ethanol, 95% 
ethanol, 80% ethanol, and 70% ethanol, and then watered 
under running water for 10-15 minutes. It was put into a 
solution of 3% H2O2 for 30 minutes, washed with PBS, put 
in 0.025% trypsin for 6 minutes at 370 C, and then washed 
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again using PBS. Afterwards, it was put into monoclonal 
antibody labeled with ALP enzyme, washed with PBS, put 
into chromogen substrates, washed with PBS, washed using 
aquadestilata, and then put into Mayer’s Haematoksilin. 
It was washed using running water, and then dehidration-
clearing-mounting was performed.11
Variables studied in this research included changes in 
both estrogen levels using ELISA and ALP expression 
using IHC examination. IHC examination was conducted 
using qualitative observation supported by quantitative 
data in one field of view. Quantitative data obtained were 
tabulated using Microsoft Office Excel, and then analyzed 
using SPSS 20.0 for Windows with Shapiro-Wilk analysis 
to determine whether the distribution of the data was 
normal or not. If the distribution of data was normal, the 
analysis would be continued using parametric analysis of 
independent t-test.
results
This research focused on the correlation between 
estrogen levels and ALP expression in all groups, used 
nine samples in each group, namely the group of normal 
rats (as the control group) and the group of OVX rats 
(osteoporosis). Normality test was conducted to determine 
the normal distribution in all the variables studied. Ekspresi 
ALP 
Table 1. Mean and standard deviation of  estrogen levels and ALP expression in the group of mandibular bone osteoporosis rats and 
the group of normal rats 
Parameter Group Mean Standard deviation Significance of difference
Estrogen
Normal 86.5091 23.19584
0.075
Osteoporosis 67.3417 25.65043
ALP
Normal 1.0000 0.75366
0.001*
Osteoporosis 4.8000 2.78959
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Figure 1. Expressions of ALP on immunereactive osteogenic cells (arrows) among the control groups of 
SHS (IHC staining, magnification 400x; H600L Nikon microscope; Fi2 300 megapixel camera 
DS).  
 
 
Figure 2. Expressions of ALP on immunereactive osteogenic cells (arrows) among the treatment groups of 
OVX (IHC staining, magnification 400x; H600L Nikon microscope; Fi2 300 megapixel camera 
DS). 
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Figure 2. Expressions of ALP on immunereactive osteogenic 
cells (arrows) among the treatment groups of OVX 
(IHC staining, magnification 400x; H600L Nikon 
microscope; Fi2 300 megapixel camera DS).
Table 2. Correlation test on estrogen levels and ALP expression 
among the research groups
Group Parameter Coefficient
Significance 
of 
correlation
Normal
Estrogen
0.162 0.635
ALP
Osteoporosis
Estrogen
-0.014 0.965
ALP
Table 1 shows that the normal group had a higher mean 
value of estrogen than the osteoporosis group. In contrary, 
the osteoporosis group had a higher mean value of ALP 
than the normal group. Based on the results of the data 
distribution test, the distribution of all data was normal, 
so the analysis was continued using parametric analysis of 
Independent t-test.
Based on the results of Independent t-test, furthermore, 
there was no significant difference in estrogen levels 
between the normal group and the osteoporosis group. 
However, there were significant differences in ALP 
expression between the normal group and the osteoporosis 
group.
The results of Pearson correlation test showed that there 
was no significant correlation between estrogen levels and 
ALP expression.
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discussion
Osteoporosis in the elderly will trigger risk of fracture 
due to a decrease in bone density. Osteoporosis is a disease 
with some distinctive properties, such as low bone mass, 
accompanied by changes in bone microarchitecture and 
deterioration of bone tissue quality, increasing risk of bone 
fragility fractures.12 Bone tissue continuously experiences 
formation and resorption (bone remodeling). At the age 
of 20 years old, bone formation process is highly active, 
far beyond bone resorption process. At the age of 20-40 
years old, both processes then are nearly active, while at 
the age of 40 years old, bone resorption process is more 
active than bone formation process, leading to decrease in 
bone density.
Osteoporosis, furthermore, can occur in the elderly 
population, especially postmenopausal women because 
of several factors, especially estrogen levels in bone 
remodeling process. Estrogen plays an important role in 
bone metabolism contributing to an increase in the number 
of osteoblasts as well as their function, and also to reduce 
bone resorption. There are estrogen receptors in osteoblasts, 
osteocytes, and osteoclasts. Estrogen also has been reported 
to have ability in increasing levels of osteoprotegerin 
(OPG), a protein produced by osteoblasts, which can inhibit 
bone resorption by preventing RANKL from binding to 
RANK receptors. Therefore, estrogen plays an important 
role in osteoclastogenesis process. Estrogen inhibits local 
factors that hinder bone formation process or increase local 
factors that stimulate bone formation process. For this 
reason, a decrease in estrogen is an important pathogenic 
factor in bone loss associated with osteoporosis.13
Examination with indirect ELISA method, moreover, 
was conducted using blood samples to determine levels of 
estrogen from their heart. The results of independent t-test 
showed that there was a significant difference (p=0.075) 
between the normal group (86.5091) and the osteoporosis 
group (67.3417). This may happen because there are other 
sources of synthesis that can replace the main source of 
estrogen in their ovaries during osteoporosis condition. 
Other sources of estrogen synthesis can be found in 
mesenchymal cells of adipose tissue, skin, osteoblasts, 
osteoclasts in bone, vascular endothelial as well as some 
places in the brain, such as preoptic medial/anterior 
hypothalamus, medial basal hypothalamus, and amygdala, 
which are only active at the level of the local tissue with a 
high concentration. 
At the beginning of osteoporosis, those sources of 
synthetic estrogen systemically controlled by the ovaries 
begin to decline. As a result, it will trigger the reactive 
properties of estrogen synthesized in the local tissue to 
get into the systemic circulation so that it can act as a 
substitute for the primary synthesis in maintaining levels of 
estrogen.14 Nevertheless, the reactive properties of estrogen 
derived from the local tissue are only temporary and occurs 
only in the early stage of osteoporosis. Osteoporosis at 
the advanced stage then would affect the local tissue in 
synthesizing estrogen so that estrogen levels in the systemic 
circulation reached its lowest level.15
Similarly, a research on model animals conducted 
by Gao16 shows that changes in hormones during 
menopause contribute to changes in body composition 
and fat distribution. Increased adipose tissue in a group of 
menopause rats triggers increased production of estrogen by 
the local tissue. Decreased ovarian function in the early stage 
of osteoporosis can also lead to an increase in adipose tissue 
mass not influenced by dietary adjustments and pathological 
metabolic conditions. Consequently, it is important to 
recognize clinically since in those ovariectomized rats 
there was an increase in fat accumulation due to estrogen 
deficiency and decreased physical activity.
In this research, ALP obtained showed a significant 
difference (p=0.001) between the normal group (1.0000) 
and the osteoporosis group (4.8000). Bone remodeling 
in osteoporosis is an ongoing process. However, bone 
resorption and bone formation cannot be balanced due to 
estrogen deficiency. This is indicated by a decline in the 
capacity of osteoblasts in the form of new bone matrix. In a 
research conducted by Lim and Kim,17 there are significant 
differences in trabecular bone mass after 12 weeks of 
post-ovariectomy in Wistar rats. Similarly, a research 
on ovariectomized Wistar rats conducted by Lasota18 
also shows that after 12 weeks of post-ovariectomy there 
are changes in bone density and bone mineral structure. 
Therefore, this research used a 12-week evaluation period 
after ovariectomy because there has been a reduction in 
bone density and bone structure representing the loss of 
bone density after menopause.
In addition, the markers of bone remodeling are a 
biochemical product measured in blood or urine reflecting 
bone metabolism activity, but not having a function as 
a controller of skeletal metabolism. Markers of bone 
remodeling are simply categorized as markers of bone 
formation. Among the markers of bone formation, ALP 
is secreted by osteoblasts towards the extracellular fluid 
that can be measured in serum.19 Besides serum activity of 
osteoblasts in bone formation process, type I collagen and 
proteoglycan can also be considered as bone matrix through 
a process, called ossification, which in the active condition 
then will produce osteoid tissue. Osteoblasts secrete a large 
amount of ALP in the process of bone formation. ALP 
plays a role in mineralization process, which is to prepare 
alkaline atmosphere (basic) in osteoid tissue formed so 
that calcium can be deposited on the tissue.20 Increased 
ALP expression then indicates osteogenic differentiation. 
During the differentiation process from pre osteoblast to 
osteoblasts, ALP activity will increase. Meanwhile, at the 
beginning of osteoblasts formation, ALP activity decrease, 
but during maturation process of osteoblasts, ALP activity 
will increase again.21
Based on the results of Pearson correlation test, there 
was no significant correlation between estrogen and ALP in 
both of the normal group and the group of ovariectomized 
rats. This is due to estrogen levels in the systemic circulation 
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affecting osteoblasts in the process of bone formation. It 
did not directly affect the activity of ALP expression in 
osteoblasts during the differentiation process from pre 
osteoblast to maturation. Similarly, Gao16 mentions that 
the expression of ALP activity changes in accordance 
with the phases of bone formation in osteoblasts, but is not 
affected by estrogen levels in the systemic circulation. In 
this research, estrogen levels also were not directly related 
to the activity of ALP expression caused by ALP expression 
changes according to the phases of bone formation.
It can be concluded that estrogen levels in model rats 
suffering from osteoporosis are lower than normal ones. 
Meanwhile, mandibular bone ALP expression in model 
rats suffering from osteoporosis is higher than normal one. 
It indicates that there is no significant correlation between 
estrogen levels and mandibular bone ALP expression in 
model rats suffering from osteoporosis and normal ones.
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